Just to clarify: Rohan said they've filed for IP protection for two CNS candidates. He said they have a focus on autophagy production (a pathway in neurogenerative diseases) and neuroinflammation (see below the patents for autophagy and inflammation). Another program PYC were working on targeting progranulin was halted due to Roche gaining the intellectual property rights. Sorrow for any confusion.
Just to clarify: Rohan said they've filed for IP protection for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |